期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
A GSH-depleted platinum(Ⅳ) prodrug triggers ferroptotic cell death in breast cancer
1
作者 Dachuan Qi Lei Xing +9 位作者 Lijun Shen Wenshuang Sun Cheng Cai chunhua xue Xuwei Song Hua Yu Hulin Jiang Chengjun Li Qingri Jin Zhiqi Zhang 《Chinese Chemical Letters》 SCIE CAS CSCD 2022年第10期4595-4599,共5页
Cisplatin is the first-line drug for treatment of various solid tumors including breast cancer due to the broad anti-tumor spectrum and strong anti-tumor effect.However,serious side effects and long-term medication of... Cisplatin is the first-line drug for treatment of various solid tumors including breast cancer due to the broad anti-tumor spectrum and strong anti-tumor effect.However,serious side effects and long-term medication of reduced sensitivity by high GSH in tumor cells have severely restricted its further clinical application.Herein,a GSH-depleted Pt(Ⅳ)prodrug(Platin B)based on cisplatin and 4-carboxylphenylboronic acid pinacol ester was prepared to solve the problems.As an excellent GSH scavenger,4-carboxylphenylboronic acid pinacol ester could be activated by intracellular redox reactions to release quinone methide,thereby amplifying oxidative stress and leading to breast cancer ferroptosis therapy.Interestingly,the consumption of GSH can also reduce cisplatin inactivation,enhance the sensitivity of tumor cells to cisplatin and efficiently induce apoptosis/ferroptosis.This work highlights the use of GSH scavenger for triggering ferroptotic cell death in breast cancer. 展开更多
关键词 CISPLATIN Ferroptosis Cancer therapy Glutathione depletion Tetravalent platinum prodrug
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部